MIN-117: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
CSV import
 
Line 1: Line 1:
'''MIN-117''' is a [[chemical compound]] that is being studied for its potential use in the treatment of [[mental health]] disorders such as [[major depressive disorder]] and [[anxiety disorder]]. It is a [[serotonin]] and [[dopamine]] reuptake inhibitor, which means it works by increasing the levels of these [[neurotransmitter]]s in the brain.
== Myocardial Infarction ==


==Chemistry==
[[File:MIN-117.svg|thumb|right|Diagram of a myocardial infarction]]
MIN-117 is a [[phenethylamine]] derivative. It is structurally related to other phenethylamine derivatives that are used as [[psychoactive drug]]s, but it has a unique mechanism of action. It inhibits the reuptake of serotonin and dopamine, two neurotransmitters that are involved in mood regulation.


==Pharmacology==
A '''myocardial infarction''' (MI), commonly known as a heart attack, occurs when blood flow decreases or stops to a part of the [[heart]], causing damage to the heart muscle. The most common symptom is chest pain or discomfort which may travel into the shoulder, arm, back, neck, or jaw. Often it occurs in the center or left side of the chest and lasts for more than a few minutes. The discomfort may occasionally feel like [[heartburn]]. Other symptoms may include shortness of breath, nausea, feeling faint, a cold sweat, or feeling tired. About 30% of people have atypical symptoms, with women more likely than men to present atypically.
The exact mechanism of action of MIN-117 is not fully understood. However, it is known that it works by inhibiting the reuptake of serotonin and dopamine. This increases the levels of these neurotransmitters in the brain, which can help to improve mood and reduce anxiety.


==Clinical trials==
== Pathophysiology ==
MIN-117 has been studied in several [[clinical trial]]s for its potential use in the treatment of major depressive disorder and anxiety disorder. The results of these trials have been promising, but further research is needed to confirm its efficacy and safety.


==Potential uses==
[[File:MIN-117.svg|thumb|left|Illustration showing the blockage of a coronary artery]]
If approved, MIN-117 could be used to treat a variety of mental health disorders, including major depressive disorder and anxiety disorder. It could also potentially be used to treat other conditions that are associated with low levels of serotonin and dopamine, such as [[Parkinson's disease]] and [[schizophrenia]].


==See also==
Myocardial infarction results from the interruption of blood supply to a part of the heart, causing heart cells to die. This is most commonly due to blockage of a [[coronary artery]] following the rupture of a vulnerable [[atherosclerotic plaque]], an unstable collection of lipids and white blood cells in the wall of an artery. The resulting ischemia and oxygen shortage, if left untreated for a sufficient period of time, can cause damage or death (infarction) of heart muscle tissue (myocardium).
* [[Serotonin–dopamine reuptake inhibitor]]
* [[Major depressive disorder]]
* [[Anxiety disorder]]


[[Category:Chemical compounds]]
== Symptoms ==
[[Category:Psychoactive drugs]]
[[Category:Serotonin–dopamine reuptake inhibitors]]
[[Category:Phenethylamines]]


{{stub}}
The classic symptoms of myocardial infarction include sudden chest pain (typically radiating to the left arm or left side of the neck), shortness of breath, nausea, vomiting, palpitations, sweating, and anxiety. Women may experience fewer typical symptoms than men, with more emphasis on shortness of breath, weakness, a feeling of indigestion, and fatigue.
 
== Diagnosis ==
 
Diagnosis of myocardial infarction is based on the patient's history, physical examination, and electrocardiogram (ECG) findings. Blood tests are also used to detect markers of myocardial damage, such as [[troponin]] and [[creatine kinase]].
 
== Treatment ==
 
Immediate treatment for myocardial infarction includes administration of [[aspirin]] to prevent further blood clotting, and [[nitroglycerin]] to relieve chest pain. In cases of ST-elevation myocardial infarction (STEMI), reperfusion therapy is indicated, which may include [[percutaneous coronary intervention]] (PCI) or [[thrombolysis]].
 
== Prevention ==
 
Prevention of myocardial infarction involves lifestyle changes and management of risk factors. This includes maintaining a healthy diet, regular physical activity, smoking cessation, and controlling conditions such as [[hypertension]], [[diabetes]], and [[hyperlipidemia]].
 
== Related pages ==
 
* [[Coronary artery disease]]
* [[Cardiac arrest]]
* [[Heart failure]]
* [[Atherosclerosis]]
 
[[Category:Cardiology]]
[[Category:Medical emergencies]]

Latest revision as of 03:41, 13 February 2025

Myocardial Infarction[edit]

File:MIN-117.svg
Diagram of a myocardial infarction

A myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow decreases or stops to a part of the heart, causing damage to the heart muscle. The most common symptom is chest pain or discomfort which may travel into the shoulder, arm, back, neck, or jaw. Often it occurs in the center or left side of the chest and lasts for more than a few minutes. The discomfort may occasionally feel like heartburn. Other symptoms may include shortness of breath, nausea, feeling faint, a cold sweat, or feeling tired. About 30% of people have atypical symptoms, with women more likely than men to present atypically.

Pathophysiology[edit]

File:MIN-117.svg
Illustration showing the blockage of a coronary artery

Myocardial infarction results from the interruption of blood supply to a part of the heart, causing heart cells to die. This is most commonly due to blockage of a coronary artery following the rupture of a vulnerable atherosclerotic plaque, an unstable collection of lipids and white blood cells in the wall of an artery. The resulting ischemia and oxygen shortage, if left untreated for a sufficient period of time, can cause damage or death (infarction) of heart muscle tissue (myocardium).

Symptoms[edit]

The classic symptoms of myocardial infarction include sudden chest pain (typically radiating to the left arm or left side of the neck), shortness of breath, nausea, vomiting, palpitations, sweating, and anxiety. Women may experience fewer typical symptoms than men, with more emphasis on shortness of breath, weakness, a feeling of indigestion, and fatigue.

Diagnosis[edit]

Diagnosis of myocardial infarction is based on the patient's history, physical examination, and electrocardiogram (ECG) findings. Blood tests are also used to detect markers of myocardial damage, such as troponin and creatine kinase.

Treatment[edit]

Immediate treatment for myocardial infarction includes administration of aspirin to prevent further blood clotting, and nitroglycerin to relieve chest pain. In cases of ST-elevation myocardial infarction (STEMI), reperfusion therapy is indicated, which may include percutaneous coronary intervention (PCI) or thrombolysis.

Prevention[edit]

Prevention of myocardial infarction involves lifestyle changes and management of risk factors. This includes maintaining a healthy diet, regular physical activity, smoking cessation, and controlling conditions such as hypertension, diabetes, and hyperlipidemia.

Related pages[edit]